Search

Your search keyword '"Sunil Dar"' showing total 3 results
Start Over Author "Sunil Dar"
3 results on '"Sunil Dar"'

1. India Hypertension Control Initiative—Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics

Author

Prabhdeep Kaur, Abhishek Kunwar, Meenakshi Sharma, Jhilam Mitra, Chinmoyee Das, Leimapokpam Swasticharan, Tapas Chakma, Sampada Dipak Bangar, Vettrichelvan Venkatasamy, Raviteja Dharamsoth, Saurabh Purohit, Sadhana Tayade, Gurinder B Singh, Sailaja Bitragunta, Kiran Durgad, Bidisha Das, Sunil Dar, Rupali Bharadwaj, Chakshu Joshi, Vishwajit Bharadwaj, Suhas Khedkar, Sravan Chenji, Sravan K Reddy, Chintala Sreedhar, Ganeshkumar Parasuraman, Savitha Kasiviswanathan, Vidhya Viswanathan, Pankaj Uike, Pooja Gaigaware, Suniti Yadav, RS Dhaliwal, Sivasubramanian Ramakrishnan, Fikru T Tullu, and Balram Bhargava

Subjects
hypertension control, India, noncommunicable diseases, raised blood pressure, Diseases of the circulatory (Cardiovascular) system, RC666-701
Abstract

Abstract The India Hypertension Control Initiative (IHCI) is a multi‐partner initiative, implementing and scaling up a public health hypertension control program across India. A cohort of 21,895 adult hypertension patients in 24 IHCI sentinel site facilities in four Indian states (Punjab, Madhya Pradesh, Maharashtra, and Telangana), registered from January 2018 until June 2019 were assessed at baseline and then followed up for blood pressure (BP) control and antihypertensive medication use. Among all registrations, 11 274 (51%) of the patients returned for a follow‐up visit between July 2019 and September 2019. Among patients returning for follow‐up, 26.3% had BP controlled at registration, and 59.8% had BP controlled at follow‐up (p

Published
2021
Full Text
View/download PDF

2. India Hypertension Control Initiative—Hypertension treatment and blood pressure control in a cohort in 24 sentinel site clinics

Author

Kiran Durgad, Sravan Chenji, Abhishek Kunwar, Sadhana Tayade, Pooja Gaigaware, Prabhdeep Kaur, Tapas Chakma, Ganesh Parasuraman, Gurinder Bir Singh, Chakshu Joshi, R S Dhaliwal, Jhilam Mitra, Suniti Yadav, Vettrichelvan Venkatasamy, Rupali Bharadwaj, Sravan K Reddy, Sunil Dar, Pankaj Uike, Sampada Dipak Bangar, Fikru Tesfaye Tullu, Bidisha Das, Balram Bhargava, Sivasubramanian Ramakrishnan, Vidhya Viswanathan, Saurabh Purohit, Chintala Sreedhar, Leimapokpam Swasticharan, Raviteja Dharamsoth, Meenakshi Sharma, Savitha Kasiviswanathan, Chinmoyee Das, Suhas Khedkar, Sailaja Bitragunta, and Vishwajit Bharadwaj

Subjects
Adult, Blood pressure control, medicine.medical_specialty, noncommunicable diseases, Endocrinology, Diabetes and Metabolism, India, Blood Pressure, Population health, 030204 cardiovascular system & hematology, hypertension control, 03 medical and health sciences, 0302 clinical medicine, Internal Medicine, Humans, Medicine, 030212 general & internal medicine, Medical prescription, raised blood pressure, Antihypertensive Agents, Original Paper, Primary Health Care, Hypertension control, business.industry, Public health, Original Papers, Sentinel site, Blood pressure, Hypertension, Cohort, Emergency medicine, Cardiology and Cardiovascular Medicine, business
Abstract

The India Hypertension Control Initiative (IHCI) is a multi‐partner initiative, implementing and scaling up a public health hypertension control program across India. A cohort of 21,895 adult hypertension patients in 24 IHCI sentinel site facilities in four Indian states (Punjab, Madhya Pradesh, Maharashtra, and Telangana), registered from January 2018 until June 2019 were assessed at baseline and then followed up for blood pressure (BP) control and antihypertensive medication use. Among all registrations, 11 274 (51%) of the patients returned for a follow‐up visit between July 2019 and September 2019. Among patients returning for follow‐up, 26.3% had BP controlled at registration, and 59.8% had BP controlled at follow‐up (p

Published
2020

3. Green synthesis and anxiolytic activity of some new dibenz-[1,4] diazepine-1-one analogues

Author

Jaiprakash N. Sangshetti, Rashmi S. Chouthe, Mohan R. Jadhav, Nikhil S. Sakle, Aniruddha Chabukswar, Indrajeet Gonjari, Sunil Darandale, and Devanand B. Shinde

Subjects
Dibenz [1,4] diazepine-1-ones, Multicomponent synthesis, Oxalic acid catalyst, Anxiolytic activity, Chemistry, QD1-999
Abstract

A facile, green approach for the synthesis of some new dibenz[1,4]-diazepine-1-one by a three component reaction of Diamine, 1,3 diketone and aromatic aldehyde using oxalic acid as catalyst in water is described. The products are formed in good yields (92–94%). Newly synthesized dibenz [1,4]-diazepine-1-one analogues were evaluated for the anxiolytic activity by the elevated plus maze method. From the activity data it is observed that compounds, 4g, 4h and 4k show promising anxiolytic activity.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results